Kaplan is a leading global financial education provider through its successful Kaplan Schweser books | 1mo
IP
Partners James Zimmerman and Scott Palmer take team to Loeb ahead of Perkins’ Beijing closure | 2mos
Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe | 1mo
Producers had opposed registration of two trademarks in long running dispute with Fontana Food | 2mos
US firm closed its Shanghai office in March | 2mos
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 2mos
Internet Archive had been sued for infringing copyright by making digital copies of print books | 2mos
Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 2mos
The way the request was processed still raises ‘significant concerns’, says the firm | 2mos
Jury’s award for vicarious infringement over contractor’s use of software overturned by judge | 2mos
Start-up Zunum offered only “vague and amorphous descriptions” of alleged theft, judge rules | 3mos
Merger marks third foray into the region aiming to offer single source for IP consultancy and services | 3mos
Olympics organisers highlight anti-counterfeiting efforts as crucial for protecting athlete funding | 3mos
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 3mos
Foley international trade lawyer Marcos Carrasco-Menchaca explains the IP rights rules for payments due on products imported into Mexico | 3mos
Foley’s Jeffrey Greene looks at how AI is revolutionising the fashion and beauty industries and issues around bias, disclosure, right of publicity and copyright | 3mos
With an eye on the UK market, Freeths’ Simon Barker and Chris Musgrave explain how to make the most of AI in advertising while managing possible IP pitfalls | 3mos
Resource aims to help businesses tackle the complex licensing landscape of SEPs | 3mos
Previous decision had upended UK’s longstanding approach to assessing patentability | 3mos
Any regulatory changes to drug patents and pricing should be wary of stifling innovation, writes Neal Gerber Eisenberg lawyer Thomas Campbell | 4mos
Copyright 2024 © The Global Legal Post. All Rights Reserved